Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat

Hypertension

Volumn 48, Issue 1, 2006, Pages 149-156

  Mattson, David L ^a   James, Leilani ^a   Berdan, Elizabeth A ^a   Meister, Carla J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Blood pressure; Hypertension; Rats; Sodium dependent

Indexed keywords

ALBUMIN; CELL MARKER; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN; SODIUM CHLORIDE; ALBUMINOID; CREATININE; DRUG DERIVATIVE; MYCOPHENOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CELL SPECIFICITY; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOSTASIS; HYPERTENSION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INDWELLING CATHETER; KIDNEY DISEASE; KIDNEY MASS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; RAT STRAIN; SALT INTAKE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DAHL SALT SENSITIVE RAT; DRUG EFFECT; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ALBUMINS; ANIMALS; BLOOD PRESSURE; CREATININE; HYPERTENSION; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; MALE; MYCOPHENOLIC ACID; PROTEINS; RATS; RATS, INBRED DAHL; SODIUM CHLORIDE;

EID: 33746016265     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000228320.23697.29     Document Type: Article

References (22)

1. Campese VM. Salt sensitivity in hypertension. Hypertension. 1994;23:531-550.
2. Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275:1581-1589.
3. Feldman HI, Klag MJ, Chiapella AP, Whelton PK. End-stage renal disease in US minority groups. Am J Kid Dis. 1992;19:397-410.
4. Grim CE, Wilson TW, Nicholson GD, Hassell TA, Fraser HS, Grim CM, Wilson DM. Blood pressure in blacks. Hypertension. 1990;15:803-809.
5. Lackland DT, Keil JE. Epidemiology of hypertension in African Americans. Sem Nephrol. 1996;16:63-70.
6. Rostand GS, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276-1279.
7. Tobian L, Lange J, Iwai J, Hiller K, Johnson MA, Goossens P. Prevention with thiazide of NaCl-induced hypertension in Dahl S rats. Hypertension. 1979;1:316-323.
8. Alvarez V, Quiroz Y, Nava M, Pons H, Rodríguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol. 2002;283:F1132-F1141.
9. Quiroz Y, Pons H, Gordon KL, Rincón J, Chávez M, Parra G, Herrera-Acosta J, Gómez-Garre D, Larfo R, Egido J, Johnson RJ, Rodríguez-Iturbe B. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthase inhibition. Am J Physiol. 2001;281:F38-F47.
10. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera-Acosta J, Johnson RJ, Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol. 2002;282:F191-F201.
11. Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol. 2004;286:F606-F616.
12. Zatz R, Noronha IL, Fujihara CK. Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies. Am J Physiol. 2002;283:1167-1175.
13. Bendich A, Belisle EH, Strausser. Immune system modulation and its effect on the blood pressure of the spontaneously hypertensive male and female rat. Biochem Biophys Res Comm. 1981;99:600-607.
14. Khraibi AA, Smith TL, Hutchins PM, Lynch CD, Dusseau JW. Thymectomy delays the development of hypertension in Okamoto spontaneously hypertensive rats. J Hypertens. 1987;5:537-541.
15. Stepkowski SM. Molecular targets for existing and novel immunosuppressive drugs. Exp Rev Mol Med [serial online]. 2000; Available at http://www. expertreviews.org/00001769h.htm. Accessed May 11, 2006.
16. Mattson DL, Kunert MP, Kaldunski ML, Greene AS, Roman RJ, Jacob HJ, Cowley AW Jr. Influence of diet and genetics on hypertension and renal disease in Dahl salt-sensitive rats. Physiol Genomics. 2004;16:194-203.
17. Mattson DL, Meister CJ, Marcelle ML. Dietary protein source determines the degree of hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension. 2005;45:736-741.
18. Weinberger MH, Miller JH, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(Suppl II):127-134.
19. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med. 1977;2:1079-1092.
20. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143.
21. Chatziantoniou C, Dussaule J-C. Insight into the mechanisms of renal fibrosis; is it possible to achieve regression? Am J Physiol. 2005;289:F227-F234.
22. Granger DN, Vowinkel T, Petnehazy T. Modulation of inflammatory response in cardiovascular disease. Hypertension. 2004;43:924-931.